Evidence map›Paper›PMID 38276612›Full record

ReviewMolecules (Basel, Switzerland)2024

Emerging Multiscale Biofabrication Approaches for Bacteriotherapy.

Roberta Rovelli, Beatrice Cecchini, Lorenzo Zavagna, Bahareh Azimi, Claudio Ricci, Semih Esin, Mario Milazzo, Giovanna Batoni, Serena Danti

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Roberta RovelliDepartment of Civil and Industrial Engineering, University of Pisa, 56122 Pisa, Italy.
Beatrice CecchiniDepartment of Civil and Industrial Engineering, University of Pisa, 56122 Pisa, Italy.
Lorenzo ZavagnaPEGASO Doctoral School of Life Sciences, University of Siena, 53100 Siena, Italy.
Bahareh AzimiDepartment of Civil and Industrial Engineering, University of Pisa, 56122 Pisa, Italy.ORCID 0009-0006-4384-4926
Claudio RicciDepartment of Civil and Industrial Engineering, University of Pisa, 56122 Pisa, Italy.ORCID 0000-0002-0110-8836
Semih EsinDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-4358-5294
Mario MilazzoDepartment of Civil and Industrial Engineering, University of Pisa, 56122 Pisa, Italy.ORCID 0000-0001-8429-5544
Giovanna BatoniDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-4448-2385
Serena DantiDepartment of Civil and Industrial Engineering, University of Pisa, 56122 Pisa, Italy.ORCID 0000-0002-8155-8537
University of Pisa · ITUniversity of Siena · IT

Funding

Ministry of Education, Universities and Research BIONUTRA (CUP B14I20001320005)
6 · The paper itself

Abstract

Bacteriotherapy is emerging as a strategic and effective approach to treat infections by providing putatively harmless bacteria (i.e., probiotics) as antagonists to pathogens. Proper delivery of probiotics or their metabolites (i.e., post-biotics) can facilitate their availing of biomaterial encapsulation via innovative manufacturing technologies. This review paper aims to provide the most recent biomaterial-assisted strategies proposed to treat infections or dysbiosis using bacteriotherapy. We revised the encapsulation processes across multiscale biomaterial approaches, which could be ideal for targeting different tissues and suit diverse therapeutic opportunities. Hydrogels, and specifically polysaccharides, are the focus of this review, as they have been reported to better sustain the vitality of the live cells incorporated. Specifically, the approaches used for fabricating hydrogel-based devices with increasing dimensionality (D)-namely, 0D (i.e., particles), 1D (i.e., fibers), 2D (i.e., fiber meshes), and 3D (i.e., scaffolds)-endowed with probiotics, were detailed by describing their advantages and challenges, along with a future overlook in the field. Electrospinning, electrospray, and 3D bioprinting were investigated as new biofabrication methods for probiotic encapsulation within multidimensional matrices. Finally, examples of biomaterial-based systems for cell and possibly post-biotic release were reported.

Indexed as

BioprintingTissue EngineeringBiocompatible MaterialsHydrogelsPrinting, Three-DimensionalTechnologyTissue ScaffoldsBiocompatible MaterialsHydrogels3D printingelectrospinningelectrospraypolysaccharidesprobioticssodium alginatetissue engineering

Identifiers

PMID38276612
PMCPMC10821506
OpenAlexW4391100297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.